'Evidence for binge drinking pill does not justify cost to NHS'.
There is 'no direct evidence' to support the effectiveness of nalmefene, the drug approved for use in the NHS in England by the National Institute for Health and Care Excellence (NICE) to curb excess drinking among those who are alcohol dependent.